9999999997-15-014831.txt : 20151123 9999999997-15-014831.hdr.sgml : 20151123 20151123103728 ACCESSION NUMBER: 9999999997-15-014831 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151123 DATE AS OF CHANGE: 20151123 20151123 20151123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 151248624 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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